Furthermore, GLI1 knockdown downregulates CD133/SOX9 expression and clonogenic ability of CRC cells, indicating this TF could be a potential marker for CSCs in CRC (Yang et al., 2018). The gene discussed is SOX9; the disease is colorectal carcinoma.